ClinConnect ClinConnect Logo
Search / Trial NCT01579370

Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)

Launched by DUKE UNIVERSITY · Apr 16, 2012

Trial Information

Current as of August 11, 2025

Completed

Keywords

Healthcare Associated Infections Multidrug Resistant Organisms Methicillin Resistant Staphylococcus Aureus Vancomycin Resistant Enterococcus Clostridium Difficile Acinetobacter

ClinConnect Summary

Meticulous and consistent use of hand hygiene before and after patient care remains the cornerstone of infection prevention in all health care settings. However, clean hands are not sufficient to prevent all healthcare-associated infections (HAIs), as 1) hands of healthcare workers easily become contaminated from contact with contaminated environmental surfaces in patient rooms after appropriate hand hygiene has been performed and before direct patient care and 2) direct contact by patients with preexisting contaminated environmental surfaces in their hospital rooms can lead to colonization...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Any seed room (ie., room from which a patient with one of the target organisms has been transferred or discharged)
  • Exclusion Criteria:
  • None, intervention is at level of the room, not the patient
  • Patient outcomes will be excluded if clinical cultures are obtained within 48 hours of admission to the room of interest.

About Duke University

Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.

Locations

Durham, North Carolina, United States

Raleigh, North Carolina, United States

Chapel Hill, North Carolina, United States

Burlington, North Carolina, United States

Raleigh, North Carolina, United States

Durham, North Carolina, United States

Durham, North Carolina, United States

High Point, North Carolina, United States

Chesapeake, Virginia, United States

Patients applied

0 patients applied

Trial Officials

Daniel J Sexton, MD

Principal Investigator

Duke University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials